Novo Nordisk A/S — Sponsor Intelligence | 108 EU Trials

Filter these 108 trials by condition, phase, country and more.

Open in Search →

108 Registered trials

29 Recruiting

73 Completed trials

25 Countries active

40 Unique IMPs

100% Results reported

Phase III

Phase II

Phase I

Phase I (Other)

Phase III: 49 Phase II/III: 1 Phase II: 13 Phase I/II: 1 Phase III/IV: 1 Phase IV: 2 Phase I: 14 Phase I (Other): 24 Other: 3

Oversight events:

11 serious breaches 1 temporary halt 1 corrective measure across 9 trials

View oversight register →

100%

73 of 73 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Obesity 9 Sickle cell disease 3 Overweight 2 Cardiac failure 2 Non-alcoholic steatohepatitis 2 Acute myocardial infarction 1 Chronic kidney disease 1 Type 2 diabetes mellitus 1 Cardiovascular disorder 1 Turner's syndrome 1 Noonan syndrome 1 Alcoholic liver disease 1

Top IMPs

SEMAGLUTIDE 19 CAGRILINTIDE, SEMAGLUTIDE 12 ZENAGAMTIDE 9 CAGRILINTIDE 7 INSULIN GLARGINE 5 ZILTIVEKIMAB 5 ETAVOPIVAT 4 INSULIN ICODEC 4 SOMAPACITAN 4 CORAMITUG 3 SOMATROPIN 3 CONCIZUMAB 2

All trials

108 total

A study to test how either a capsule or a tablet with NDec (Decitabine and Tetrahydrouridine) works in the body of healthy people Not authorised

2023-504582-22-00 Phase I 1 country
A research study on how well cagrilintide and CagriSema work in children and adolescents with excess body weight Pending

2023-509176-42-00 Phase III/IV 14 countries CAGRILINTIDE; CAGRILINTIDE, SEMAGLUTIDE; SEMAGLUTIDE
A Single Arm, Open Label, Phase 1/2 Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients with Sickle Cell D… Pending

2024-519881-32-00 Phase I/II 1 country ETAVOPIVAT
A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults with Type 2 D… Pending

2024-520068-32-00 Phase IV 2 countries INSULIN DEGLUDEC; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN ICODEC
A research study to see how NNC0487-0111 affects the body’s energy use after a weight loss in adults living with obesity, compared to a low-… Pending

2025-522744-40-00 Phase I (Other) 2 countries
A study to see how safe a new medicine (NNC6022-0004) is in healthy people and people living with obesity Pending

2026-525179-26-00 Phase I 1 country
AMAZE 8: A research study investigating how well the medicine NNC0487-0111 compared to semaglutide helps people with excess body weight and … Recruiting

2024-520446-31-00 Phase III 7 countries SEMAGLUTIDE; ZENAGAMTIDE
CLEOPATTRA: A research study to look at the effects of treatment with a medicine called coramitug (NNC6019-0001) in people with heart failur… Recruiting

2024-518899-31-00 Phase III 8 countries CORAMITUG
A study understanding how much CDR132L enters the bloodstream after injection under the skin compared to injection into a vein in healthy p… Recruiting

2025-521329-34-00 1 country
AMAZE 2: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and type 2 diabetes lose wei… Recruiting

2024-520441-23-00 Phase III 5 countries ZENAGAMTIDE
A research study looking into blood levels of the medicine NNC0487 0111 in the body and how well it is tolerated in people with reduced live… Recruiting

2025-521647-20-00 Phase I (Other) 1 country
AMAZE 1: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight lose weight Recruiting

2024-520440-42-00 Phase III 4 countries ZENAGAMTIDE
AMAZE 4: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and obstructive sleep apnoea… Recruiting

2024-520443-16-00 Phase III 3 countries ZENAGAMTIDE
A research study investigating the effect of NNC0497-0040 in healthy participants, participants with overweight or obesity, and participants… Recruiting

2025-523978-16-00 Phase I 1 country
AMAZE 3: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and obstructive sleep apnoea… Recruiting

2024-520442-36-00 Phase III 4 countries ZENAGAMTIDE
A research study to evaluate the safety of NNC1679-0001 when given to healthy participants and participants with T2DM Recruiting

2025-523304-68-00 Phase I 1 country
A research study comparing how well different doses of the medicine NNC0662-0419 lower blood sugar in people with type 2 diabetes Recruiting

2025-523260-20-00 Phase II 6 countries NNC0662-0419; SEMAGLUTIDE
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 Phase III 10 countries ZENAGAMTIDE
AMAZE 12: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight maintain their weight loss Recruiting

2025-523804-62-00 Phase III 8 countries ZENAGAMTIDE
A research study to compare blood levels of cagrilintide after multiple doses of different versions of cagrilintide in adults with overweigh… Recruiting

2025-521384-12-00 1 country
A research study looking into how cagrilintide influences food intake and appetite in people with overweight or obesity Recruiting

2025-524206-15-00 Phase I (Other) 1 country
AMAZE 5: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and knee osteoarthritis lose… Recruiting

2024-520444-42-00 Phase III 6 countries ZENAGAMTIDE
AMAZE 6: A research study investigating how well the medicine NNC0487-0111 helps people with excess body weight and knee osteoarthritis lose… Recruiting

2024-520445-23-00 Phase III 6 countries ZENAGAMTIDE
Understanding the effect of CagriSema, cagrilintide, and semaglutide on muscle health Recruiting

2025-522920-28-00 Phase I (Other) 1 country

Showing 1–24 of 108 trials

← All sponsors A–Z